Replimune Group, Inc. (REPL)
12.96
-0.07
(-0.54%)
USD |
NASDAQ |
Sep 16, 16:00
13.00
+0.04
(+0.31%)
Pre-Market: 08:34
Replimune Group Max Drawdown (5Y) : 95.70% for Aug. 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| August 31, 2026 | 95.70% |
| July 31, 2026 | 95.70% |
| June 30, 2026 | 95.70% |
| May 31, 2026 | 95.70% |
| April 30, 2026 | 95.70% |
| March 31, 2026 | 94.67% |
| February 28, 2026 | 94.67% |
| January 31, 2026 | 94.67% |
| December 31, 2025 | 94.67% |
| November 30, 2025 | 94.67% |
| October 31, 2025 | 94.67% |
| September 30, 2025 | 94.67% |
| August 31, 2025 | 94.67% |
| July 31, 2025 | 94.67% |
| June 30, 2025 | 90.48% |
| May 31, 2025 | 90.48% |
| April 30, 2025 | 90.48% |
| March 31, 2025 | 90.48% |
| February 28, 2025 | 90.48% |
| January 31, 2025 | 90.48% |
| December 31, 2024 | 90.48% |
| November 30, 2024 | 90.48% |
| October 31, 2024 | 90.48% |
| September 30, 2024 | 90.48% |
| August 31, 2024 | 90.48% |
| Date | Value |
|---|---|
| July 31, 2024 | 90.48% |
| June 30, 2024 | 90.48% |
| May 31, 2024 | 90.48% |
| April 30, 2024 | 88.32% |
| March 31, 2024 | 87.18% |
| February 29, 2024 | 87.18% |
| January 31, 2024 | 87.18% |
| December 31, 2023 | 87.18% |
| November 30, 2023 | 80.66% |
| October 31, 2023 | 74.70% |
| September 30, 2023 | 74.70% |
| August 31, 2023 | 74.70% |
| July 31, 2023 | 74.70% |
| June 30, 2023 | 74.70% |
| May 31, 2023 | 74.70% |
| April 30, 2023 | 74.70% |
| March 31, 2023 | 74.70% |
| February 28, 2023 | 74.70% |
| January 31, 2023 | 74.70% |
| December 31, 2022 | 74.70% |
| November 30, 2022 | 74.70% |
| October 31, 2022 | 74.70% |
| September 30, 2022 | 74.70% |
| August 31, 2022 | 74.70% |
| July 31, 2022 | 74.70% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Moderna, Inc. | 95.38% |
| Kalaris Therapeutics, Inc. | 99.79% |
| Arrowhead Pharmaceuticals, Inc. | 88.96% |
| Oncolytics Biotech, Inc. | 92.83% |
| Sangamo Therapeutics, Inc. | 99.68% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -25.82 |
| Beta (5Y) | 0.9379 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 128.5% |
| Historical Sharpe Ratio (5Y) | -0.1347 |
| Historical Sortino (5Y) | -0.3451 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 33.04% |